Journal of the American Medical Association · 1955 · 16 citations · 6 references
MedicineDermatologyPharmacotherapyChemotherapyDermatopathologyImmunopharmacotherapyChronic Actinic DermatitisTopical PreparationsAntimalarial AgentsCutaneous Lichen PlanusDaily DosingTablets
Chloroquine phosphate, primarily an antimalarial and amebacidal drug, has been used with considerable success in the treatment of chronic discoid lupus erythematosus<sup>1</sup>and in actinic dermatitis.<sup>2</sup>Because of its efficacy in these dermatoses, it was almost inevitable that it would be used in other dermatoses on an empirical basis. We first became interested in trying it in other dermatoses after using it with considerable benefit in a case of lichen planus. This, of course, led us to try it first in other cases of lichen planus as they became available and subsequently in a variety of unrelated dermatoses that had been treatment problems. <h3>METHOD AND RESULTS</h3> Chloroquine (Aralen) phosphate (tablets 250 mg., containing 150 mg. of chloroquine base) was prescribed to be taken orally, usually twice daily for one week, then once daily. In a few cases, the twice daily dose was continued beyond one week or was
6
STUDIES ON THE CHRONIC TOXICITY OF CHLOROQUINE (SN-7618) 1
Alf S. Alving, Lillian Eichelberger, Branch Craige et al. · Journal of Clinical Investigation · 1948 · 118 citations · Full text
Medicine, Pharmacology, Toxicology +14
George G. Haydu · The American Journal of the Medical Sciences · 1953 · 36 citations
Light Sensitive Eruptions Treated with Atabrine and Chloroquine
John M. Knox, John H. Lamb, Bedford Shelmire et al. · Journal of Investigative Dermatology · 1954 · 23 citations · Full text